Mark Carter

Mark Carter is a PMO Leader at Cytiva, with a robust background in business transformation, portfolio governance, and strategic program delivery within highly regulated industries. With 28 years of experience in the pharmaceutical, radiopharmaceutical, and biotechnology sectors, Mark excels in project management and organizational governance. They have played a pivotal role in significant initiatives such as the Cytiva/Pall merger and the Danaher acquisition, demonstrating expertise in managing complex global operations and stakeholder communications. Previously, Mark held multiple leadership positions at Bio Products Laboratory and GE Healthcare, contributing to compliance management, engineering systems, and project oversight. Mark’s educational credentials include a BEng (Hons) in Electrical and Electronic Engineering and completion of the Management Development Programme at the University of Westminster.